Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.54 |
| ▸ | EGLN1 | Q9GZT9 | 3/20 | 0.48 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.44 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | ABAT | P80404 | 1/20 | 0.43 |
| ▸ | APEX1 | P27695 | 1/20 | 0.43 |
| ▸ | PTPRC | P08575 | 2/20 | 0.43 |
| ▸ | CTSL | P07711 | 1/20 | 0.43 |
| ▸ | PTPN13 | Q12923 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | ABL1 | P00519 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodohippurate SCHEMBL29959499 | 1.00 | KMT2A (0.58) | KMT2AMEN1TDP1KEAP1EGLN1 | |
| Iodohippurate SCHEMBL2142713 | 0.98 | KMT2A (0.56) | KMT2AMEN1TDP1KEAP1EGLN1 | |
| Iodohippurate SCHEMBL5915006 | 0.98 | KMT2A (0.56) | KMT2AMEN1TDP1KEAP1EGLN1 | |
| Iodohippurate SCHEMBL9860635 | 0.98 | KMT2A (0.56) | KMT2AMEN1TDP1KEAP1EGLN1 | |
| SCHEMBL31448014 | 0.86 | KEAP1 (0.62) | KMT2AKEAP1EGLN1KDM4CKDM4E | |
| SCHEMBL5532912 | 0.86 | KEAP1 (0.51) | KMT2AMEN1TDP1KEAP1EGLN1 | |
| SCHEMBL11325406 | 0.84 | KMT2A (0.51) | KMT2AMEN1TDP1KEAP1SIGMAR1 | |
| SCHEMBL8814831 | 0.84 | KMT2A (0.51) | KMT2AMEN1TDP1KEAP1SIGMAR1 | |
| Iodohippurate SCHEMBL5915003 | 0.82 | KMT2A (0.50) | KMT2AMEN1TDP1KEAP1SIGMAR1 | |
| Iodohippurate SCHEMBL1652159 | 0.82 | KMT2A (0.50) | KMT2AMEN1TDP1KEAP1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 418 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240350644-A1 | STEREOCOMPLEXES FOR THE DELIVERY OF ANTI-CANCER AGENTS | TIEN DER YANG (US) | 2024-10-24 | — | — | US | claimed |
| CN-118184679-A | Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material | 中国石油天然气股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-115671286-B | Stereocomplex for delivery of anticancer agents | 田德扬 | 2023-12-08 | — | — | CN | claimed |
| EP-4137527-A1 | STEREOCOMPLEXES FOR THE DELIVERY OF ANTI-CANCER AGENTS | TIEN, Der-Yang (US) | 2023-02-22 | — | — | EP | claimed |
| CN-115671286-A | Stereocomplex for delivery of anticancer agents | 田德扬 | 2023-02-03 | — | — | CN | claimed |
| CN-113260653-B | Stereocomplex for delivery of anticancer agents | 田德扬 | 2022-11-04 | — | — | CN | claimed |
| EP-3891207-B1 | STEREOCOMPLEXES FOR THE DELIVERY OF ANTI-CANCER AGENTS | TIEN DER YANG (US) | 2022-11-02 | — | — | EP | claimed |
| US-20220072139-A1 | STEREOCOMPLEXES FOR THE DELIVERY OF ANTI-CANCER AGENTS | TIEN DER YANG (US) | 2022-03-10 | — | — | US | claimed |
| EP-3891207-A1 | STEREOCOMPLEXES FOR THE DELIVERY OF ANTI-CANCER AGENTS | TIEN, Der-Yang (US) | 2021-10-13 | — | — | EP | claimed |
| WO-2020117742-A1 | STEREOCOMPLEXES FOR THE DELIVERY OF ANTI-CANCER AGENTS | TIEN DER YANG (US) | 2020-06-11 | — | — | WO | claimed |
| CN-100482284-C | Tracer or labelled isotope microbubble reagent with target substance and usage thereof | WEI WU (CN) | 2009-04-29 | — | — | CN | claimed |
| US-20070060906-A1 | Method, reagent, and device for embolizing blood vessels in tumors with ultrasonic radiation micro-bubble reagent | WU WEI | 2007-03-15 | — | — | US | claimed |
| US-20060019205-A1 | Thermographic materials processable at lower temperatures | EASTMAN KODAK COMPANY | 2006-01-26 | — | — | US | claimed |
| CN-1669586-A | Tracer or labelled isotope microbubble reagent with target substance and usage thereof | WU WEI (CN) | 2005-09-21 | — | — | CN | claimed |
| US-5225182-A | For specific organ delivery | SHARMA YASH P (US) | 1993-07-06 | — | — | US | claimed |
| US-5021220-A | Haluaromatic compound, water-soluble acid, copper salt acid-stable reducing agent | MALLINCKRODT, INC. (US) | 1991-06-04 | — | — | US | claimed |
| US-4883650-A | Radioidohippuric acid ester, a conjugate thereof, and methods of making the same | ALBERT EINSTEIN COLLEGE OF MEDICINE - OF YESHIVA UNIVERSITY (US) | 1989-11-28 | — | — | US | claimed |
| EP-0165630-B1 | METHOD OF PREPARING A CHLORINATED, BROMINATED, RADIOBROMINATED, IODINATED AND/OR RADIOIODINATED, AROMATIC OR HETEROAROMATIC COMPOUND, AS WELL AS A KIT FOR PREPARING A DIAGNOSTIC COMPOSITION ON THE BASIS OF THIS COMPOUND | MALLINCKRODT, INC.(a Missouri corporation) (US) | 1989-10-18 | — | — | EP | claimed |
| EP-0165630-A2 | Method of preparing a chlorinated, brominated, radiobrominated, iodinated and/or radioiodinated, aromatic or heteroaromatic compound, as well as a kit for preparing a diagnostic composition on the basis of this compound | MALLINCKRODT, INC.(a Missouri corporation) (US) | 1985-12-27 | — | — | EP | claimed |
| US-4192859-A | MEDICAL DIAGNOSIS USING X-RAYS | E. R. SQUIBB & SONS, INC. (US) | 1980-03-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220072139-A1 | STEREOCOMPLEXES FOR THE DELIVERY OF ANTI-CANCER AGENTS | TOP2A, TSG101, TOP1 | KMT2A 4641/4885MEN1 1549/4885TDP1 1435/4885 |
| US-20240350644-A1 | STEREOCOMPLEXES FOR THE DELIVERY OF ANTI-CANCER AGENTS | TOP2A, TSG101, TOP1 | KMT2A 4641/4885MEN1 1549/4885TDP1 1435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.